Statement of Purpose

The Inhalation Focus Group (IFG) is a focus group within the Academy of Pharmaceutical Sciences open to all members with an interest in pulmonary and nasal drug delivery. The IFG is lead by a Steering Group (J Clarke [Pfizer], P Colthorpe [Novartis], S Fayinka [GSK], B Forbes [KCL], R Price [Uni. Bath] and P Seville [Uni. Aston]) which will act to facilitate & co-ordinate interaction between the wider membership and promote the group's activities.

Aims

• Provide a forum for Industry, Academe and the Regulators to engage in discussion of current issues in science, technology & regulation pertinent to pulmonary and nasal drug delivery.
• Collaborate and coordinate with other relevant organizations active in the field (e.g. Aerosol Society, EPAG, AAPS ITFG) with a view to establishing joint meetings and dialogue in the field.
• Provide continuing education for the membership via for e.g. a biennial symposium, interim focussed workshops/seminars.

Areas of interest

• Particle production technologies
• Drug delivery technologies
• Formulation technologies
• Novel technologies and methods to understand, control, predict and improve drug product performance, processability and stability.
• In vitro characterisation techniques